Therefore, loss of LMTK2 can contribute to microglia activation and neuroinflammation in neurodegenerative diseases by activating GSK3β and blocking the anti-inflammatory effect of Nrf2. The gene discussed is GSK3B; the disease is neurodegenerative disease.